DEUTERATED ISOXAZOLE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS
申请人:AstraZeneca AB
公开号:US20170145002A1
公开(公告)日:2017-05-25
The present application relates to a compound of Formula (I), and to uses thereof, such as for the treatment of a neurological or psychoartic disorder.
本申请涉及一种化合物的公式(I),以及其用途,例如用于治疗神经系统或精神障碍。
DEUTERATED PHENYL AMINO PYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
申请人:Suzhou Zelgen Biopharmaceuticals Co. Ltd.
公开号:EP2949647B1
公开(公告)日:2020-08-05
Oxazolidinone derivatives and methods of use
申请人:Tung Roger
公开号:US20090093422A1
公开(公告)日:2009-04-09
This invention relates to novel N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide derivatives, their acceptable acid addition salts, solvates and hydrates. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by antimicrobial agents.
Synthesis of deuterated morpholine derivatives
申请人:Liu Julie F.
公开号:US20100160247A1
公开(公告)日:2010-06-24
The present invention is directed to a process for preparing a 2,26,6-d
4
-morpholine derivative represented by Structural Formula (I):
or a salt thereof.
SYNTHESIS OF DEUTERATED MORPHOLINE DERIVATIVES
申请人:Liu Julie F.
公开号:US20130281456A1
公开(公告)日:2013-10-24
The present invention is directed to a process for preparing a 2,26,6-d
4
-morpholine derivative represented by Structural Formula (I):
or a salt thereof.